Main Street Financial Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.6M Sell
2,420
-1,644
-40% -$1.57M 0.19% 106
2025
Q3
$3.1M Buy
4,064
+592
+17% +$441K 0.2% 107
2025
Q2
$2.71M Buy
3,472
+923
+36% +$717K 0.2% 113
2025
Q1
$2.11M Buy
2,549
+234
+10% +$195K 0.18% 124
2024
Q4
$1.79M Sell
2,315
-60
-3% -$49.7K 0.18% 111
2024
Q3
$2.1M Sell
2,375
-570
-19% -$512K 0.19% 109
2024
Q2
$2.67M Buy
2,945
+564
+24% +$451K 0.25% 81
2024
Q1
$1.85M Buy
2,381
+1,505
+172% +$1.07M 0.2% 106
2023
Q4
$511K Buy
876
+21
+2% +$12.3K 0.07% 259
2023
Q3
$459K Sell
855
-551
-39% -$284K 0.07% 266
2023
Q2
$659K Sell
1,406
-408
-22% -$171K 0.09% 213
2023
Q1
$624K Buy
1,814
+504
+38% +$170K 0.09% 221
2022
Q4
$481K Buy
1,310
+487
+59% +$173K 0.08% 245
2022
Q3
$266K Buy
+823
New +$261K 0.04% 353

Other funds holding LLY

Main Street Financial Solutions's LLY Position: Q4 2025 in Review

Main Street Financial Solutions reduced its Eli Lilly (LLY) stake by 40% in Q4 2025, selling an estimated $1.57M and leaving 2,420 shares worth $2.6M. The position accounts for 0.19% of the portfolio, ranked #106.

Main Street Financial Solutions first reported a position in LLY in Q3 2022 and has held it in 14 quarters since. The position peaked at $3.1M in Q3 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Main Street Financial Solutions held 2,420 shares of Eli Lilly worth $2.6M as of Q4 2025.
  • Main Street Financial Solutions sold 1,644 Eli Lilly shares in Q4 2025, an estimated $1.57M.
  • Eli Lilly made up 0.19% of Main Street Financial Solutions's portfolio in Q4 2025, its #106 holding.
  • Main Street Financial Solutions first reported a position in Eli Lilly in Q3 2022 and has held it in 14 quarters since.
  • Main Street Financial Solutions's Eli Lilly position peaked at $3.1M in Q3 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.